XULANE LOW Trademark

Trademark Overview

On Friday, October 27, 2023, a trademark application was filed for XULANE LOW with the United States Patent and Trademark Office. The USPTO has given the XULANE LOW trademark a serial number of 98243175. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, May 20, 2025. This trademark is owned by Mylan Pharmaceuticals Inc.. The XULANE LOW trademark is filed in the Pharmaceutical Products category with the following description:

Transdermal contraceptives
xulane low

General Information

Serial Number98243175
Word MarkXULANE LOW
Filing DateFriday, October 27, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, May 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2024

Trademark Statements

Goods and ServicesTransdermal contraceptives
NOT AVAILABLELOW

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 3, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMylan Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26506
Party NameMylan Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26506

Trademark Events

Event DateEvent Description
Tuesday, October 31, 2023NEW APPLICATION ENTERED
Wednesday, February 7, 2024ASSIGNED TO EXAMINER
Friday, February 16, 2024NON-FINAL ACTION WRITTEN
Friday, November 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 16, 2024NON-FINAL ACTION E-MAILED
Friday, February 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 6, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 26, 2024PUBLISHED FOR OPPOSITION
Thursday, November 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 14, 2024SOU EXTENSION 1 FILED
Thursday, November 14, 2024SOU EXTENSION 1 GRANTED
Tuesday, May 20, 2025SOU TEAS EXTENSION RECEIVED
Thursday, November 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 20, 2025SOU EXTENSION 2 FILED
Tuesday, May 20, 2025SOU EXTENSION 2 GRANTED
Wednesday, May 21, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

xulane contraceptives transdermal